Dexcom to introduce OTC glucose sensor
By HME News Staff
Updated 9:09 AM CST, Wed March 6, 2024
SAN DIEGO – Dexcom has received clearance from the U.S. Food and Drug Administration for its Stelo by Dexcom, a continuous glucose monitor that will be available for people with Type 2 diabetes without a prescription. “Dexcom continues to lead innovation in the CGM market, with a long list of first-in-market advances,” said Jake Leach, executive vice president and COO. “Dexcom was the first to connect CGM to multiple insulin delivery devices, the first to connect CGM to a smartphone, the first to replace fingersticks for treatment decisions, and now is creating a new category by bringing the first glucose biosensor cleared for use over-the-counter. Based on our experience serving people with Type 2 diabetes not using insulin, we have developed Stelo with their unique needs in mind.” Stelo will be available for purchase online without a prescription starting summer 2024. To learn more about Stelo: https://www.dexcom.com/en-us/stelo.
Comments